First, identify who is actually behind the page
Three page types look alike at a glance, and they behave differently once you submit a form.
- A sponsor, university, or health-system page. There is a named institution, a research unit, and usually a phone number you can call without filling anything in.
- A registry-style record. The page reads like a structured database entry rather than an advertisement, and it exists to describe a study, not to collect inquiries.
- A lead-generation landing page. The page's main visible purpose is a short form, often with a headline and an image but little detail about who runs the study.
The distinction matters because it determines who answers your questions and who ends up holding your contact details. A lead-generation page may route your form to a site you have never heard of. Google's publisher policies bar ads on content that misrepresents who is behind a page or falsely implies an affiliation or endorsement, which is a useful reason to treat an unnamed page as a question rather than a fact. That is a publishing standard, not proof about any particular listing.
Expect the inquiry itself to have stages: a form or call, a phone screen, a records release, then an in-person screening visit. Ask at the first stage who will contact you, from which number, and how soon — a site that cannot name its next step is one to slow down with.
Scrutinize the claim wording, not the promise
Certain phrasings should slow you down regardless of how reassuring the rest of the page looks:
- a guaranteed benefit, or language implying you will do better than standard care;
- "free" treatment stated as a headline fact rather than as something to confirm;
- urgency scripts — a closing enrollment window, a limited number of spots, a callback deadline;
- hints that you will get a therapy before it is broadly available;
- a request for payment, card details, or a full medical history before any conversation.
Google's content policies disallow ads on content that promotes harmful health claims or contradicts authoritative scientific consensus, and they disallow using false or ambiguous content to induce interaction. Its publisher restrictions also flag pages that facilitate online sales of prescription drugs, which is worth remembering if a recruitment page doubles as a product pitch. Read these as consumer-protection signals: a page can carry persuasive copy and still be legitimate, so treat the wording as a prompt for questions, not a verdict.
Convert design labels into questions for the study team
Words like randomized, placebo-controlled, blinded, and phase describe how a study is built; they do not tell you what you personally will receive. Ask directly, and ask for the answer in writing:
- Which treatment would I receive, and what is the chance I receive the comparison or placebo instead?
- What exactly is the comparison — an approved drug, usual care, or nothing?
- Who will know which group I am in, and will I be told at any point?
- What is the total number of visits, and how long does each one take?
- What happens if I want to stop, and does stopping affect my usual care?
- Is there a screening period, and what does it involve?
If an answer comes back vague, ask the same question in a different form. Confirm any definition in the listing with the study team rather than relying on what the label seems to mean to you.
Ask about money, time, and travel before you commit
No national figure applies here. Cost coverage, reimbursement, and time burden vary by sponsor and by individual site, so treat every number you are given as specific to that study and that location.
- Which procedures are billed to the study, and which go to my insurance?
- Is travel, parking, or mileage reimbursed, and how is it paid?
- Are there stipends for time, and does receiving one affect anything else?
- What is the expected total time commitment, including phone screens?
- Can visits be scheduled around work, school, or caregiving?
- Who is my single point of contact if something changes?
Write the answers down and keep them next to the listing, because two sites running related studies may answer differently, and a community clinic and an academic center may not offer the same practical support or the same reimbursement process.
Ask about your records before you hand them over
A records release is a real step, not paperwork. Before you sign one:
- Who receives my records, and is the release limited to this study?
- Is a signed authorization required, or will a verbal screen come first?
- What happens to my information if I am screened out or decide not to continue?
- Will my own diabetes clinician be told that I inquired?
- Who else can see my data, and for how long is it kept?
You can ask these questions before answering any of the study team's. An informed-consent conversation is where the study's purpose, procedures, and alternatives should be explained, and participation is meant to be voluntary; confirm those points with the team rather than assuming them from a web page.
Where this checklist stops
This article is a preparation checklist, not medical advice, and it was built without clinical or registry sources — only general publishing and advertising standards were available. That is why no enrollment figures, eligibility thresholds, costs, or outcomes appear here. Nothing in it should be read as a determination that a specific listing is trustworthy or untrustworthy.
Your next step is narrow: use the questions above on the one page in front of you, then confirm every study-specific detail with the study team and with your own diabetes care team before you change anything about your care.
研究の知恵